跳至主要内容
临床试验/EUCTR2005-001214-40-GB
EUCTR2005-001214-40-GB进行中(未招募)1 期

A trial to compare the effects of nebivolol versus atenolol on various cardiovascular measurements including insulin sensitivity - Nebivolol trial

Imperial College London0 个研究点目标入组 50 人开始时间: 2007年8月1日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Hypertension;
  • BP <160/90 on no antihypertensive drugs, BP <140/85 on two drugs, BP 140-170/90 on 1 drug.
  • Male or female of any age.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Compelling indication for beta blockers
  • Contra-indication to or previous intolerance of thiazide diuretics or beta blockers
  • Concurrent treatment with verapamil/diltiazem
  • Heart Failure
  • AV conduction disturbances
  • Atrial fibrilation
  • Co-existing clinically important conditions which may interfere with the study

研究者

相似试验

A trial to compare the effects of nebivolol versus... | 临床试验